Logo image of R3NK.DE

RENK GROUP AG (R3NK.DE) Stock Fundamental Analysis

FRA:R3NK - Deutsche Boerse Ag - DE000RENK730 - Common Stock - Currency: EUR

24.105  -0.2 (-0.82%)

Fundamental Rating

3

R3NK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 107 industry peers in the Machinery industry. R3NK has a bad profitability rating. Also its financial health evaluation is rather negative. R3NK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year R3NK was profitable.
In the past year R3NK had a positive cash flow from operations.
R3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFR3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.38%, R3NK is in line with its industry, outperforming 41.58% of the companies in the same industry.
R3NK has a Return On Equity (5.26%) which is in line with its industry peers.
R3NK has a Return On Invested Capital (5.90%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for R3NK is below the industry average of 8.38%.
The last Return On Invested Capital (5.90%) for R3NK is above the 3 year average (4.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.38%
ROE 5.26%
ROIC 5.9%
ROA(3y)0.87%
ROA(5y)N/A
ROE(3y)3.25%
ROE(5y)N/A
ROIC(3y)4.1%
ROIC(5y)N/A
R3NK.DE Yearly ROA, ROE, ROICR3NK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

R3NK has a Profit Margin of 1.94%. This is comparable to the rest of the industry: R3NK outperforms 45.54% of its industry peers.
The Operating Margin of R3NK (8.61%) is better than 68.32% of its industry peers.
R3NK's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 22.95%, R3NK is doing worse than 79.21% of the companies in the same industry.
R3NK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.61%
PM (TTM) 1.94%
GM 22.95%
OM growth 3Y2.38%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5YN/A
R3NK.DE Yearly Profit, Operating, Gross MarginsR3NK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 20

More info and screens

3

2. Health

2.1 Basic Checks

R3NK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for R3NK remains at a similar level compared to 1 year ago.
The debt/assets ratio for R3NK has been reduced compared to a year ago.
R3NK.DE Yearly Shares OutstandingR3NK.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
R3NK.DE Yearly Total Debt VS Total AssetsR3NK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500M 1B

2.2 Solvency

R3NK has an Altman-Z score of 2.58. This is not the best score and indicates that R3NK is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.58, R3NK is in the better half of the industry, outperforming 64.36% of the companies in the same industry.
R3NK has a debt to FCF ratio of 8.08. This is a slightly negative value and a sign of low solvency as R3NK would need 8.08 years to pay back of all of its debts.
R3NK has a Debt to FCF ratio (8.08) which is comparable to the rest of the industry.
R3NK has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
R3NK's Debt to Equity ratio of 1.37 is on the low side compared to the rest of the industry. R3NK is outperformed by 85.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF 8.08
Altman-Z 2.58
ROIC/WACC0.96
WACC6.17%
R3NK.DE Yearly LT Debt VS Equity VS FCFR3NK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

R3NK has a Current Ratio of 1.83. This is a normal value and indicates that R3NK is financially healthy and should not expect problems in meeting its short term obligations.
R3NK has a Current ratio of 1.83. This is comparable to the rest of the industry: R3NK outperforms 58.42% of its industry peers.
R3NK has a Quick Ratio of 1.83. This is a bad value and indicates that R3NK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, R3NK is doing worse than 60.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 0.92
R3NK.DE Yearly Current Assets VS Current LiabilitesR3NK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.44% over the past year.
Looking at the last year, R3NK shows a quite strong growth in Revenue. The Revenue has grown by 9.01% in the last year.
Measured over the past years, R3NK shows a very strong growth in Revenue. The Revenue has been growing by 81.43% on average per year.
EPS 1Y (TTM)100.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.83%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y81.43%
Revenue growth 5YN/A
Sales Q2Q%10.52%

3.2 Future

Based on estimates for the next years, R3NK will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.82% on average per year.
R3NK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.13% yearly.
EPS Next Y-0.49%
EPS Next 2Y17.53%
EPS Next 3Y19.44%
EPS Next 5Y19.82%
Revenue Next Year18.95%
Revenue Next 2Y17.01%
Revenue Next 3Y15.97%
Revenue Next 5Y15.13%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
R3NK.DE Yearly Revenue VS EstimatesR3NK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
R3NK.DE Yearly EPS VS EstimatesR3NK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 120.52 indicates a quite expensive valuation of R3NK.
Based on the Price/Earnings ratio, R3NK is valued a bit more expensive than the industry average as 65.35% of the companies are valued more cheaply.
R3NK is valuated expensively when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.38, which indicates a rather expensive current valuation of R3NK.
Based on the Price/Forward Earnings ratio, R3NK is valued a bit more expensive than 66.34% of the companies in the same industry.
R3NK is valuated cheaply when we compare the Price/Forward Earnings ratio to 95.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 120.53
Fwd PE 18.38
R3NK.DE Price Earnings VS Forward Price EarningsR3NK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, R3NK is valued a bit more expensive than the industry average as 72.28% of the companies are valued more cheaply.
R3NK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 36.3
EV/EBITDA 17.18
R3NK.DE Per share dataR3NK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

R3NK's earnings are expected to grow with 19.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.53%
EPS Next 3Y19.44%

More info and screens

2

5. Dividend

5.1 Amount

R3NK has a Yearly Dividend Yield of 1.25%. Purely for dividend investing, there may be better candidates out there.
R3NK's Dividend Yield is comparable with the industry average which is at 3.14.
Compared to an average S&P500 Dividend Yield of 2.28, R3NK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.25%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
R3NK.DE Yearly Dividends per shareR3NK.DE Yearly Dividends per shareYearly Dividends per share 2024 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y17.53%
EPS Next 3Y19.44%
R3NK.DE Yearly Income VS Free CF VS DividendR3NK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

More info and screens

RENK GROUP AG

FRA:R3NK (2/5/2025, 5:29:56 PM)

24.105

-0.2 (-0.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners9.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.41B
Analysts84.21
Price Target31.97 (32.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.02%
Min EPS beat(2)6.21%
Max EPS beat(2)19.83%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)2.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.52%
PT rev (3m)0.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-11.38%
EPS NY rev (3m)12.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 120.53
Fwd PE 18.38
P/S 2.29
P/FCF 36.3
P/OCF 22.9
P/B 6.21
P/tB 86.34
EV/EBITDA 17.18
EPS(TTM)0.2
EY0.83%
EPS(NY)1.31
Fwd EY5.44%
FCF(TTM)0.66
FCFY2.75%
OCF(TTM)1.05
OCFY4.37%
SpS10.51
BVpS3.88
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 5.26%
ROCE 8.5%
ROIC 5.9%
ROICexc 6.36%
ROICexgc 10.01%
OM 8.61%
PM (TTM) 1.94%
GM 22.95%
FCFM 6.32%
ROA(3y)0.87%
ROA(5y)N/A
ROE(3y)3.25%
ROE(5y)N/A
ROIC(3y)4.1%
ROIC(5y)N/A
ROICexc(3y)4.67%
ROICexc(5y)N/A
ROICexgc(3y)8.02%
ROICexgc(5y)N/A
ROCE(3y)5.91%
ROCE(5y)N/A
ROICexcg growth 3Y58.83%
ROICexcg growth 5YN/A
ROICexc growth 3Y58.8%
ROICexc growth 5YN/A
OM growth 3Y2.38%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5YN/A
F-Score7
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF 8.08
Debt/EBITDA 3.16
Cap/Depr 50.37%
Cap/Sales 3.7%
Interest Coverage 250
Cash Conversion 62.76%
Profit Quality 325.06%
Current Ratio 1.83
Quick Ratio 0.92
Altman-Z 2.58
F-Score7
WACC6.17%
ROIC/WACC0.96
Cap/Depr(3y)35.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.6%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.83%
EPS Next Y-0.49%
EPS Next 2Y17.53%
EPS Next 3Y19.44%
EPS Next 5Y19.82%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y81.43%
Revenue growth 5YN/A
Sales Q2Q%10.52%
Revenue Next Year18.95%
Revenue Next 2Y17.01%
Revenue Next 3Y15.97%
Revenue Next 5Y15.13%
EBIT growth 1Y44.95%
EBIT growth 3Y85.75%
EBIT growth 5YN/A
EBIT Next Year42.98%
EBIT Next 3Y27.17%
EBIT Next 5Y23.65%
FCF growth 1Y-41%
FCF growth 3Y239.33%
FCF growth 5YN/A
OCF growth 1Y-30.02%
OCF growth 3Y68.58%
OCF growth 5YN/A